OrbusNeich Medical Group Holdings Limited (FRA:Q8T)

Germany · Delayed Price · Currency is EUR

0.3680

-0.0040 (-1.08%)

At close: Aug 26, 2026

-21.37% (1Y)

Market Cap	351.89M -18.5%
Revenue (ttm)	171.22M +15.9%
Net Income	38.24M +7.4%
EPS	0.05 +7.3%
Shares Out	n/a
PE Ratio	9.20
Forward PE	8.93
Dividend	0.02 (5.88%)
Ex-Dividend Date	Sep 18, 2026

Volume	n/a
Open	0.3680
Previous Close	0.3720
Day's Range	0.3680 - 0.3680
52-Week Range	0.2940 - 0.5100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About FRA:Q8T

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, drug-coated balloons and stents for lesion therapy, non-compliant balloons for post-dilatation, and specialty catheters, as well as microcatheters, guide catheter extension, dual therapy, and drug eluting stents. Its ... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 2001

Employees 1,528

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol Q8T

Financial Performance

In 2025, FRA:Q8T's revenue was $180.45 million, an increase of 9.97% compared to the previous year's $164.10 million. Earnings were $41.90 million, an increase of 5.49%.

Financial numbers in USD Financial Statements